Ivermectin for COVID-19: real-time meta analysis of 63 studies
Covid Analysis, Sep 9, 2021, Version 117 — discussion updates (V1 Nov 26, 2020) [GMK response, Elgazzar, Carvallo]
- Meta analysis using the most serious outcome reported shows 69% [54‑79%]and 86% [75‑92%]improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis and restriction to peer-reviewed studies or Randomized Controlled Trials.
- Statistically significant improvements are seen formortality,hospitalization, recovery, cases, and viral clearance. 29 studies show statistically significant improvements in isolation.
Studies | Prophylaxis | Early treatment | Late treatment | Patients | Authors | |
All studies | 63 | 86% [75‑92%] | 69% [54‑79%] | 40% [24‑52%] | 26,422 | 623 |
Peer-reviewed | 45 | 86% [74‑93%] | 70% [52‑81%] | 43% [21‑59%] | 17,316 | 490 |
Randomized Controlled Trials | 31 | 84% [25‑96%] | 64% [48‑74%] | 30% [2‑50%] | 6,561 | 369 |
Percentage improvement with ivermectin treatment |
Leave a Reply